|
 INDIANAPOLIS (AP) - Heart device maker Guidant Corp. said Wednesday its board has decided to hold discussions with Boston Scientific Corp.'s about its $25 billion offer for Guidant, which seeks to scuttle a standing, although lower, deal with Johnson & Johnson.
Boston Scientific said it was ready to begin due diligence to confirm all the pertinent facts of the offer.
On Monday, Boston Scientific offered about $72 per share for Guidant, consisting of $36 in cash and a fixed number of Boston Scientific shares valued $36 a piece.
|